← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 9, 2022Last known activity
Nov 5, 2025
Timeline
2020s
- Jul 8, 2020
Suzhou Medilink Therapeutics Ltd.— Founded
Drugs by trial phase (17 distinct, 17 trials)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (10 own, 0 via acquisition)
Recent trials (17)
- NCT07258979Lead sponsorPhase 1/Phase 2Nov 5, 2025
- NCT07208773Lead sponsorPhase 1/Phase 2Oct 29, 2025
- NCT07202364Lead sponsorPhase 2Oct 15, 2025
- NCT07197827Lead sponsorPhase 1/Phase 2Sep 22, 2025
- NCT07111520CollaboratorPhase 1/Phase 2Sep 22, 2025
- NCT07169994Lead sponsorPhase 1/Phase 2Sep 2, 2025
- NCT06859762Lead sponsorPhase 1Jul 2, 2025
- NCT06629597Lead sponsorPhase 3Dec 1, 2024
- NCT06612151Lead sponsorPhase 3Dec 1, 2024
- NCT06384352Lead sponsorPhase 1May 1, 2024
- NCT06439771Lead sponsorPhase 2Apr 23, 2024
- NCT06394414Lead sponsorPhase 1Apr 17, 2024
- NCT06241846Lead sponsorPhase 2Feb 22, 2024
- NCT06107686Lead sponsorPhase 2Dec 31, 2023
- NCT06057922Lead sponsorPhase 1/Phase 2Sep 22, 2023
Details
- Founded
- Suzhou, CN Jul 8, 2020
- Last known activity
- Nov 5, 2025